Aphria Inc (TSX:APHA) Gets the Green Light for Expansion: Should You Buy the Stock?

Aphria Inc (TSX:APHA)(NYSE:APHA has received approval from Health Canada to go ahead with its planned expansion. Time to buy?

If any Canadian marijuana producer has had a wild ride over the past year, it would have to be Aphria (TSX:APHA)(NYSE:APHA). After a fourth quarter of 2018 that included short attacks, lawsuits, and a hostile takeover bid, the company entered 2019 with a major management shakeup that fundamentally transformed the company.

For months afterward, it was all quiet on the Aphria front. But now, the company is back in the news with an announcement that it has received clearance from Health Canada to pursue a major expansion project. This news is a signal that Aphria could be gearing up for even more growth after increasing revenue 154% year over year in its most recent quarter. To understand why this news is so big, we need to take a look at what exactly Health Canada approved.

Health Canada approves expansion

For marijuana growers, nothing is more important than production space. The ability to meet the growing demand for cannabis in this country requires significant grow space, and so far, the cannabis growers don’t have enough of it. As a result, the post legalization era has been marked by major supply shortages.

For Aphria, that may be about to change. Earlier this month, Health Canada approved an 800,000-square-foot expansion to the Aphria One grow space in Leamington. This new space will have the capacity to produce 110,000 kg of marijuana a year for about $800 million in revenue at the current cannabis selling price.

$1 billion in revenue predicted

Partially as a result of the recent expansion, Aphria is now forecasting $1 billion in revenue by the end of 2020. The math behind this makes sense given the figures above: the space the company is adding will be able to generate $800 million a year, and that’s on top of the company’s existing space, which drove about $13 million in sales in the most recent quarter. This would represent phenomenal revenue growth, the only question being whether demand for cannabis will be strong enough to justify it.

Takeover seems unlikely

A final point about Aphria is worth mentioning — this one pertaining to the much-discussed hostile takeover bid from Green Growth Brands.

Thanks to all the good news coming from Aphria, it seems unlikely that the Green Growth bid will go through. The all-stock bid valued Aphria at about $9, but with the company’s meteoric growth, its stock has risen to $13 so far this year. Assuming this price level holds, Aphria will be well out of Green Growth’s reach. This is good news for Aphria shareholders, since it means they won’t be forced to exchange each of their shares for 1.5 shares in a much less proven enterprise. This, combined with the recently approved expansion, indicates that this once maligned company may have a bright future ahead of it.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned.

More on Cannabis Stocks

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »

Cannabis Stocks

Why This Little-Known Cannabis Stock Could Double in 2024

This cannabis stock has already doubled this year since 52-week lows and could easily rise that much once more.

Read more »

Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 420-Foot Pole

Down 87% from all-time highs, Cronos Group stock is a still a high-risk investment for long-term shareholders in 2024.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth: Buy, Sell, or Hold?

Canopy Growth (TSX:WEED) stock should make a killing on U.S. expansion, but investors will need to be very patient.

Read more »